NCT04398420View on ClinicalTrials.gov

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

NATerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Benign Prostatic Hypertrophy
Interventions
DEVICE

TVERP

Transurethral Vapor Enucleation Resection of the prostate

DEVICE

TURis

Transurethral Vapor Enucleation Resection of the prostate

DEVICE

HoLEP

Transurethral Vapor Enucleation Resection of the prostate

Trial Locations (3)

310003

West China Hospital, Sichuan University, Chengdu

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

430060

Renmin Hospital,Wuhan University, Wuhan

Sponsors
All Listed Sponsors
lead

Olympus Surgical Technologies Europe

INDUSTRY